Trials / Completed
CompletedNCT00653562
Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography
Single Blind, Multi-center, Post Marketing Clinical Study of Zolpidem (Myslee) in Adolescent Patients With Insomnia - Evaluation With Polysomnography
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of zolpidem for adolescent insomniacs with polysomnography
Detailed description
The study consists of two parts. All patients will receive placebo in one part and Zolpidem in the other part in a single blind manner. Efficacy will be measured with polysomnography .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zolpidem | Oral |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-04-07
- Last updated
- 2017-02-17
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00653562. Inclusion in this directory is not an endorsement.